Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Goldman Sachs keeps Neutral on Pfizer, citing unclear product growth plans and focus on M&A amid changing market valuations ...

Nevertheless, Albert Bourla has been lobbying the U.S. government—as high as President Donald Trump himself—to skip the ...

Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US.Albery Bourla said there ...

Unlike other companies grappling with evolving trade policy, Pfizer didn't revise its full-year outlook Tuesday.

The Manila Times is one of the leading national broadsheets in the Philippines. It is also one of the oldest, having been founded in 1898. PR Newswire ...

Pfizer Inc. (NYSE: PFE) today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) ...

Simultaneously, the company maintained its strong commitment to shareholders by declaring a quarterly dividend. Pfizer's share price saw a modest increase of 1.59% over the past week, aligning ...

As Pfizer navigates these challenges, it faces rising competition from agile biotech firms wielding AI, gene editing, and mRNA technologies. By 2030, these innovators could surpass Pfizer’s drug ...

The company’s strong financial position is evident in its healthy current ratio of 4.68, indicating robust liquidity to support its expansion plans. In addition to supporting Pfizer’s global ...

Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the sector, which pharma giant Pfizer privately warned could damage the Irish ...